1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 10226253, compound

HRID 1839416Notes

Reaction equation

HRID 1839416 reaction equation
[NH:1]([C:8]1[N:9]([C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=2)[C:10]2[C:15]([C:16](=[O:18])[CH:17]=1)=[C:14]([S:19][CH2:20][C:21]([OH:23])=O)[N:13]=[C:12]([CH3:24])[CH:11]=2)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CCN=C=N[CH2:36][CH2:37][CH2:38][N:39](C)C.C1C=CC2N(O)N=NC=2C=1.C1(N)CC1>C(Cl)Cl>[NH:1]([C:8]1[N:9]([C:25]2[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=2)[C:10]2[C:15]([C:16](=[O:18])[CH:17]=1)=[C:14]([S:19][CH2:20][C:21]([NH:39][CH:38]1[CH2:36][CH2:37]1)=[O:23])[N:13]=[C:12]([CH3:24])[CH:11]=2)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

6

Procedure

To a mixture of [(2-anilino-7-methyl-4-oxo-1-phenyl-1,4-dihydro-1,6-naphthyridin-5-yl)sulfanyl]acetic acid (20 mg, 0.05 mmol), EDCI (18 mg, 0.10 mmol), HOBT (13 mg, 0.10 mmol) and cyclopropylamine (0.004 mL, 0.06 mmol) in CH2Cl2 (5 mL) was added TEA (0.02 mL, 0.14 mmol). The reaction solution was stirred at room temperature for 24 h before the mixture was diluted with CH2Cl2, washed with 0.5N HCl, saturated aqueous NaHCO3, brine and dried over Na2SO4. Solvents were removed in vacuo and the residue was purified by reverse-phase preparative HPLC (10% CH3CN in water with 0.1% TFA to 95% CH3CN in water, 10 mL/min, 10 min) to provide 2-[(2-anilino-7-methyl-4-oxo-1-phenyl-1,4-dihydro-1,6-naphthyridin-5-yl)sulfanyl]-N-cyclopropylacetamide (13 mg, 59%): LCMS RT: 2.55 min, MH+: 457.1.

Workup

  1. washwashed with 0.5N HCl, saturated aqueous NaHCO3, brine
  2. dry with materialdried over Na2SO4
  3. customSolvents were removed in vacuo
  4. customthe residue was purified by reverse-phase preparative HPLC (10% CH3CN in water with 0.1% TFA to 95% CH3CN in water, 10 mL/min, 10 min)

Sources & evidence

ORD record
ord-32c256152775432dbe72e0c2e25f695f
Source dataset
uspto-grants-2004_01
Patent number
US06677352B1

Reaction notes

Loading…